Ted Hoffman

affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

127

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

The Follow-On Biologics Market: Enter at Your Own Risk

Number of pages: 18 Posted: 08 Dec 2011
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 127 (234,139)

Abstract:

Loading...

generics, follow-on biologics, biosimilars, interchangeablility, FDA, biologics, innovation, incumbent, BLA, NDA, Biologics Price Competition and Innovation Act, 2010 Patient Protection and Affordable Care Act, Data Exclusivity, patents